It is Novo Nordisk's next-generation weight loss drug, and the clinical trial data is some of the most impressive in obesity research to date: more than 20 percent average weight loss, with 60 percent of participants losing 20 percent or more of their body weight
In light of these emerging findings, this review systematically evaluates current evidence on gut microbiotas mechanistic involvement in PCOS, with particular attention to microbial metabolites and their systemic effects, while critically assessing the translational potential of microbiome-targeted interventions for this complex endocrine disorder
Some patients start with a short series of NAD+ treatments for deeper support, then move to maintenance sessions spaced weeks or months apart
Many people find that taking liposomal glutathione on an empty stomach or about 20 minutes before a meal leads to the best results
CrossRef Depression and increased cancer risk: a 10-year population-based cohort study Chang-Hwan Baek, Hyeon Ji Kim, Minkook Son, Hye Ryeon Kim, Seong Hwan Kim, Hyun Soo Kim Social Psychiatry and Psychiatric Epidemiology.2026;[Epub] CrossRef Longitudinal remodeling of gastric microbiota following Helicobacter pylori eradication reveals an eradication-associated microbial signature in gastric cancer Chin-Hee Song, Yonghoon Choi, Nayoung Kim, Sungchan Ha, Ji Hyun Park, Ho-Kyoung Lee, Cheol Min Shin, Soyeon Ahn Frontiers in Cellular and Infection Microbiology.2026;[Epub] CrossRef Intermuscular adipose tissue as a prognostic biomarker for overall survival in colorectal cancer Doyoun Kim, Hye Sun Lee, Jae-Hoon Lee, Jeonghyun Kang European Journal of Radiology.2026
